Vanguard Global Advisers’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.1K Hold
15,599
– – ﹤0.01% 3279
2026
Q2
$20.6K Hold
15,599
– – ﹤0.01% 3324
2026
Q1
$21.4K Buy
+15,599
New +$23.6K ﹤0.01% 3291

Other funds holding MNOV

Vanguard Global Advisers's MNOV Position: Q3 2026 in Review

Vanguard Global Advisers held its MediciNova (MNOV) position steady in Q3 2026 at 15,599 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3279.

Vanguard Global Advisers first reported a position in MNOV in Q1 2026 and has held it in 3 quarters since. 38 funds tracked by Wall St. Rank hold MNOV as of Q3 2026.

  • Vanguard Global Advisers held 15,599 shares of MediciNova worth $26.1K as of Q3 2026.
  • Vanguard Global Advisers left its MediciNova share count unchanged in Q3 2026.
  • MediciNova made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3279 holding.
  • Vanguard Global Advisers first reported a position in MediciNova in Q1 2026 and has held it in 3 quarters since.
  • 38 funds tracked by Wall St. Rank held MediciNova as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.